Scientific Papers

Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes | Journal of Ovarian Research


  • Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219–31.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.

    Article 

    Google Scholar
     

  • Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8(1):41.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • McCartney CR, Marshall JC. Polycystic Ovary Syndrome. Solomon CG, ed. N Engl J Med. 2016;375(1):54–64.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update. 2009;15(4):477–88.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Dapas M, Dunaif A. Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification. Endocr Rev. 2022;43(6):927–65.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Stener-Victorin E. Update on animal models of polycystic ovary syndrome. Endocrinology. 2022;163(12):bqac164.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Caldwell ASL, Middleton LJ, Jimenez M, et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology. 2014;155(8):3146–59.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mannerås L, Cajander S, Holmäng A, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 2007;148(8):3781–91.

    Article 
    PubMed 

    Google Scholar
     

  • Bourgneuf C, Bailbé D, Lamazière A, et al. The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nat Commun. 2021;12(1):1064.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Labrie F, Luu-The V, Bélanger A, et al. Is dehydroepiandrosterone a hormone? J Endocrinol. 2005;187(2):169–96.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Olaniyan OT, Bamidele O, Uche S, et al. Ovarian metabolic activity in dehydroepiandrosterone-induced polycystic ovary in wistar rats treated with aspirin. JBRA Assist Reprod. 2020;24(1):41–54.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shen Q, Bi H, Yu F, et al. Nontargeted metabolomic analysis of skeletal muscle in a dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome. Mol Reprod Dev. 2019;86(4):370–8.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wu G, Hu X, Ding J, Yang J. The effect of glutamine on dehydroepiandrosterone-induced polycystic ovary syndrome rats. J Ovarian Res. 2020;13(1):57.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shen HR, Xu X, Ye D, Li XL. Berberine improves the symptoms of DHEA-Induced PCOS rats by regulating gut microbiotas and metabolites. Gynecol Obstet Invest. 2021;86(4):388–97.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhang X, Zhang C, Shen S, et al. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats. Hum Reprod. 2013;28(11):3074–85.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Li SY, Song Z, Song MJ, Qin JW, Zhao ML, Yang ZM. Impaired receptivity and decidualization in DHEA-induced PCOS mice. Sci Rep. 2016;6(1):38134.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dou L, Zheng Y, Li L, et al. The effect of cinnamon on polycystic ovary syndrome in a mouse model. Reprod Biol Endocrinol. 2018;16(1):99.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;86(5):1–12.

    Article 

    Google Scholar
     

  • Osuka S, Nakanishi N, Murase T, et al. Animal models of polycystic ovary syndrome: A review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides. Reprod Med Biol. 2019;18(2):151–60.

    Article 
    PubMed 

    Google Scholar
     

  • Lai H, Jia X, Yu Q, et al. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome1. Biol Reprod. 2014;91(5):1–11.

    Article 

    Google Scholar
     

  • Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89(2):453–62.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88.

    Article 
    PubMed 

    Google Scholar
     

  • Poojary PS, Nayak G, Panchanan G, et al. Distinctions in pcos induced by letrozole Vs dehydroepiandrosterone with high-fat diet in mouse model. Endocrinology. 2022;163(9):bqac097.

    Article 
    PubMed 

    Google Scholar
     

  • Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687–708.

    Article 
    PubMed 

    Google Scholar
     

  • Boutzios G, Karalaki M, Zapanti E. Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact Ferti Endocrine. 2013;43(2):314–7.

    CAS 

    Google Scholar
     

  • Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism. 2004;53(3):358–76.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Weiss EP, Villareal DT, Fontana L, Han DH, Holloszy JO. Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging. 2011;3(5):533–42.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tchernof A, Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol. Published online July 1, 2004:1–14.

  • De Pergola G. The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int J Obes. 2000;24(S2):S59–63.

    Article 

    Google Scholar
     

  • Wang F, He Y, Santos HO, Sathian B, Price JC, Diao J. The effects of dehydroepiandrosterone (DHEA) supplementation on body composition and blood pressure: a meta-analysis of randomized clinical trials. Steroids. 2020;163:108710.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lovejoy JC, Bray GA, Bourgeois MO, et al. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women–a clinical research center study. J Clin Endocrinol Metab. 1996;81(6):2198–203.

    CAS 
    PubMed 

    Google Scholar
     

  • Elbers JMH, Asscheman H, Seidell JC, Megens JAJ, Gooren LJG. Long-term testosterone administration increases visceral fat in female to male transsexuals1. J Clin Endocrinol Metab. 1997;82(7):2044–7.

    CAS 
    PubMed 

    Google Scholar
     

  • Liu S, Yao Q, Li X, et al. Effects of a ketogenic diet on reproductive and metabolic phenotypes in mice with polycystic ovary syndrome. Biol Reprod. 2023;108(4):597–610.

    Article 
    PubMed 

    Google Scholar
     

  • Xie Q, Xiong X, Xiao N, et al. Mesenchymal stem cells alleviate DHEA-induced polycystic ovary syndrome (PCOS) by Inhibiting Inflammation in Mice. Stem Cells Int. 2019;2019:e9782373.

    Article 

    Google Scholar
     

  • Jang M, Lee MJ, Lee JM, et al. Oriental Medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats. PLoS ONE. 2014;9(2):e87623.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link